PMID- 10810246 OWN - NLM STAT- MEDLINE DCOM- 20000711 LR - 20190607 IS - 1021-7770 (Print) IS - 1021-7770 (Linking) VI - 7 IP - 3 DP - 2000 May-Jun TI - Acute cross-tolerance to opioids in heroin delta-opioid-responding Swiss Webster mice. PG - 258-69 AB - It is generally thought that the mu receptor actions of metabolites, 6-monoacetylmorphine (6MAM) and morphine, account for the pharmacological actions of heroin. However, upon intracerebroventricular (i.c.v.) administration in Swiss Webster mice, heroin and 6MAM act on delta receptors while morphine acts on mu receptors. Swiss Webster mice made tolerant to subcutaneous (s.c.) morphine by morphine pellet were not cross-tolerant to s.c. heroin (at 20 min in the tail flick test). Now, opioids were given in combination, s.c. (6.5 h) and i.c.v. (3 h) preceding testing the challenging agonist i.c.v. (at 10 min in the tail flick test). The combination (s.c. + i.c.v.) morphine pretreatment induced tolerance to the mu action of morphine but no cross-tolerance to the delta action of heroin, 6MAM and DPDPE and explained why morphine pelleting did not produce cross-tolerance to s.c. heroin above. Heroin plus heroin produced tolerance to delta agonists but not to mu agonists. Surprisingly, all combinations of morphine with the delta agonists produced tolerance to morphine which now acted through delta receptors (inhibited by i.c.v. naltrindole), an unusual change in receptor selectivity for morphine. FAU - Rady, J J AU - Rady JJ AD - Research Service, Clement J. Zablocki Veterans Affairs Medical Center and Medical College of Wisconsin, Milwaukee, Wisc., USA. FAU - Fujimoto, J M AU - Fujimoto JM LA - eng GR - DA00451/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - J Biomed Sci JT - Journal of biomedical science JID - 9421567 RN - 0 (Analgesics, Opioid) RN - 0 (Drug Implants) RN - 0 (Morphine Derivatives) RN - 0 (Narcotics) RN - 0 (Receptors, Opioid, delta) RN - 0 (Receptors, Opioid, mu) RN - 100929-53-1 (Enkephalin, Ala(2)-MePhe(4)-Gly(5)-) RN - 451W47IQ8X (Sodium Chloride) RN - 5S6W795CQM (Naltrexone) RN - 70D95007SX (Heroin) RN - 76I7G6D29C (Morphine) RN - 88373-73-3 (Enkephalin, D-Penicillamine (2,5)-) RN - G167Z38QA4 (naltrindole) RN - M5E47P1ZCH (6-O-monoacetylmorphine) SB - IM MH - Analgesics, Opioid/pharmacology MH - Animals MH - Behavior, Animal/drug effects MH - Cross Reactions MH - Drug Implants/administration & dosage MH - Drug Tolerance/*physiology MH - Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology MH - Enkephalin, D-Penicillamine (2,5)-/pharmacology MH - Heroin/*pharmacology MH - Injections, Intraventricular MH - Injections, Subcutaneous MH - Male MH - Mice MH - Morphine/administration & dosage/pharmacology MH - Morphine Derivatives/pharmacology MH - Naltrexone/analogs & derivatives/pharmacology MH - Narcotics/*pharmacology MH - Pain Measurement MH - Receptors, Opioid, delta/agonists/*drug effects/physiology MH - Receptors, Opioid, mu/agonists/*drug effects/physiology MH - Sodium Chloride/pharmacology MH - Time Factors EDAT- 2000/05/16 09:00 MHDA- 2000/07/15 11:00 CRDT- 2000/05/16 09:00 PHST- 2000/05/16 09:00 [pubmed] PHST- 2000/07/15 11:00 [medline] PHST- 2000/05/16 09:00 [entrez] AID - 25457 [pii] AID - 10.1007/BF02255475 [doi] PST - ppublish SO - J Biomed Sci. 2000 May-Jun;7(3):258-69. doi: 10.1007/BF02255475.